JUNS | JUPITER NEUROSCIENCES, INC. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	9.73 - 11.98
52 Week Range	3.86 - 19.51
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	509,538
Average Volume	669,392
Shares Outstanding	32,876,400
Market Cap	319,887,372
Sector	Healthcare
Industry	Biotechnology
IPO Date	2022-01-18

Valuation
Profitability
Growth
Health
P/E Ratio	-121.62
Forward P/E Ratio	N/A
EPS	-0.08
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	4
Country	USA
Website	JUNS

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer's disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida.

JUNS's peers: VISN, KLDO

*Chart delayed

Analyzing fundamentals for JUNS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see JUNS Fundamentals page.

Watching at JUNS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on JUNS Technicals page.